Written by Ad OpsOverview and Naming
CBD #1 x Purple PCK 2002 is a mostly indica hybrid devised by ACE Seeds, a breeder known for preserving landrace genetics and boutique chemotypes. The cross marries a CBD-dominant line (CBD #1) with a highly pigmented Pakistan Chitral Kush selection from 2002—often abbreviated as Purple PCK 2002. In practice, the combination seeks to deliver the calm clarity of CBD with the richly colored, resin-heavy aesthetics of classic hashplant Kush.
Growers and consumers often gravitate to this cross for three reasons: predictable indica structure, accessible CBD-led effects, and ornamental violet-to-nearly-black flowers under cooler flowering conditions. Inhaled effects tend to be composed and body-forward when the CBD phenotype is selected, while balanced and THC-leaning phenotypes can show a more traditional Kush weight. The absence of live third-party lab summaries at the time of writing means most insights come from breeder intent, parent-line data, and pattern recognition across comparable chemotypes.
For clarity, the naming indicates a direct filial cross rather than a long, stabilized cultivar line. That means phenotype expression can vary, especially in cannabinoid ratios, color intensity, and terpene emphasis. Careful selection from a seed run can lock in the exact experience—CBD-dominant calm paired with purple hash-kush perfume—that many buyers of this cross are seeking.
Breeding History and Context
ACE Seeds bred CBD #1 x Purple PCK 2002 to fuse a modern CBD-rich backbone with an old-world Kush chosen in 2002 for color, resin, and robustness. CBD #1 is ACE’s CBD-dominant platform, typically yielding high CBD readings with very low THC, designed to produce non-intoxicating or minimally intoxicating chemotypes. Purple PCK 2002 refers to a particularly dark, anthocyanin-saturated Pakistan Chitral Kush selection known for berry-jam aromatics, hashish resin density, and durable outdoor performance.
The strategic goal was to carry over CBD #1’s chemotype while preserving the classic indica morphology, early finishing time, and sensory identity of PCK. In effect, this cross channels a 1990s–early 2000s hashplant Kush profile into a 2020s CBD use case. That blend reflects a broader market trend: consumers want heritage flavors without the overpowering intoxication associated with high-THC-only cultivars.
Historically, Pakistan Chitral Kush lines have earned fame in European breeding circles for stability, mildew resilience in temperate climates, and striking purple expression without requiring extreme cold. CBD-dominant crosses into such landrace-derived Kush foundations have proven effective at buffering THC-related side effects for sensitive users. ACE Seeds’ approach fits into this lineage-first philosophy: preserve landrace character while tailoring modern cannabinoid targets.
Genetic Lineage and Inheritance Patterns
CBD #1 contributes a CBDAS-active allele set, predisposing progeny to CBD-forward outcomes, while Purple PCK 2002 most commonly carries active THCAS associated with THC-dominant chemotypes. When a CBD-dominant plant is crossed with a THC-dominant plant, F1 chemotypes often segregate into CBD-dominant, balanced (CBD:THC ≈ 1:1), and THC-dominant groups. Under simple Mendelian assumptions for a single-locus model (CBDAS vs THCAS), the expected distribution is roughly 25% CBD-dominant, 50% balanced, and 25% THC-dominant, though real-world outcomes can deviate due to polygenic modifiers and selection.
In practice, many growers report three practical phenotypic buckets: ultra-mellow CBD-led plants with minimal intoxication; “therapeutic balanced” plants that feel noticeably stronger but manageable; and classic Kush-leaning plants with deeper euphoria and couchlock. The purple coloration is largely independent of cannabinoid outcome and is driven by anthocyanin expression regulated by temperature, light intensity, and genetics. A 10–15°F (5–8°C) day–night swing in late flower reliably unlocks deeper purple, with some phenotypes showing coloration even at warm nights due to high anthocyanin baseline.
Aromatic inheritance tends to skew toward Purple PCK’s berry-jam and hash resin notes, with CBD #1 contributing fresher green, floral, and light citrus top-notes. Resin gland morphology in this cross typically shows dense capitate-stalked trichomes, favoring both solventless and hydrocarbon extraction. Because this is a seed cross rather than a clone-only release, growers should expect variation and plan to select mothers if they aim for repeatable CBD-led outcomes.
Morphology and Visual Traits
Plants are compact and indica-forward, commonly reaching 70–110 cm indoors without aggressive training, and 120–180 cm outdoors depending on season length and root volume. Internodal spacing is short (often 3–6 cm), enabling dense cola formation and reduced staking needs compared to lankier hybrids. Leaves display broad, paddle-like leaflets with a dark, glossy cuticle, a hallmark of Kush heritage.
Under optimal conditions, calyxes swell into hard, golf-ball clusters that stack into spear colas with high trichome density. Purple PCK 2002 genetics drive anthocyanin accumulation, producing flowers that range from lavender to deep eggplant, often with contrasting lime-green sugar leaves. Cooler nights in the final 2–3 weeks, especially sub-64°F (18°C), intensify coloration without sacrificing resin.
Trichome coverage is conspicuous, with abundant capitate-stalked heads preferred for hashmaking. Visual estimates in similar PCK-derived lines show total cannabinoid-rich resin easily exceeding 18–22% of dry flower mass in THC-dominant phenotypes; in CBD-dominant phenotypes, resin remains thick but the active fraction shifts to CBD. Pistils mature from cream to amber-brown in late flower, and a frosted appearance persists through cure due to robust gland head integrity.
Aroma Spectrum and Bouquet
The bouquet heavily borrows from Purple Pakistan Chitral Kush: macerated blackberry, blackcurrant preserves, and hashish spice. Secondary notes often include sandalwood, cacao nib, and faint incense, especially after a slow cure. CBD #1 contributes brighter top notes—sweet hay, meadow flowers, and a light peel of lemon-lime—lifting the base into a more nuanced, layered fragrance.
Freshly ground flowers can swing between berry custard and resinous forest floor depending on phenotype and cure length. In balanced plants, a peppery snap and faint diesel-mineral edge may appear, likely from higher beta-caryophyllene and humulene expression. Terpene intensity improves markedly with a 60/60 dry (60°F/15.5°C and 60% RH) and 4–8 weeks of cure, preserving volatile monoterpenes while letting sesquiterpenes bloom.
Total terpene content in related indica and CBD-dominant cultivars commonly ranges from 1.2% to 3.5% w/w in well-grown, properly dried flowers, according to multi-year datasets from legal-state labs. Expect the highest aromatic payoff when plants are harvested at peak ripeness, then trimmed and jarred with minimal handling. Drying too quickly above 70°F (21°C) and below 50% RH tends to collapse the top-note complexity and mute the jam-like core.
Flavor and Mouthfeel
On inhalation, the flavor starts with sweet berry marmalade and soft hash resin, reminiscent of old-school hand-rubbed charas but cleaner. Mid-palate, mild pepper and cocoa appear, with a waxy, coating mouthfeel that persists into the exhale. Well-cured samples introduce a delicate floral-lime lift from CBD #1, adding freshness to the Kush density.
In vaporization, lower temperatures (170–185°C / 338–365°F) emphasize blackberry jam, violet floral, and citrus zest. Higher temperatures (190–205°C / 374–401°F) unlock peppery resin, sandalwood, and earthy cacao, with deeper throat hit. Balanced phenotypes may show a faint diesel-mineral accent, while CBD-dominant phenos tend to taste cleaner and greener, especially early in cure.
Salinity and mineral content of water used during late flower can subtly influence perceived flavor clarity. Growers who maintain stable EC and avoid overfeeding in the final 10–14 days often report a brighter, less muddy finish. Glass-cured samples at 58–62% RH retain volatile top notes better than drier cures below 55% RH.
Cannabinoid Profile and Ratios
With no public live testing specific to CBD #1 x Purple PCK 2002 at the time of writing, expectations come from parent lines and similar CBD x Kush crosses. CBD #1, as presented by ACE Seeds, is typically CBD-dominant with very low THC, often advertised with CBD:THC ratios greater than 15:1. Purple PCK lines are traditionally THC-dominant, commonly testing in the teens for THC percentage in modern grows, though exact values vary with environment and selection.
In F1 seed lots from CBD-dominant x THC-dominant pairings, real-world lab results across CBD breeding programs often cluster into three bands. CBD-dominant phenotypes frequently show CBD in the 8–16% range with THC at or below ~1% (CBD:THC ≈ 15:1 to 25:1). Balanced phenotypes often fall near 5–10% CBD and 5–10% THC (CBD:THC ≈ 1:1), while THC-leaning phenotypes may show THC in the teens with CBD below ~2%.
Inhalation onset and pharmacokinetics differ by ratio: CBD-dominant flowers typically produce subtle head effects with pronounced body relaxation and reduced intoxication. Balanced flowers trend toward fuller euphoria and analgesia due to pharmacodynamic synergy (the “entourage effect”), as suggested in mixed-cannabinoid clinical literature. Because variability is inherent, growers and patients should rely on third-party COAs and keep phenotype-tagged samples to maintain consistent cannabinoid delivery.
Dominant Terpenes and Volatile Compounds
Across legal-market datasets (e.g., Washington State I-502 analyses and multi-lab summaries published 2016–2022), indica-leaning cultivars commonly express beta-myrcene, beta-caryophyllene, and limonene as the top three terpenes. In CBD-rich cultivars, linalool and ocimene sometimes rise, contributing floral and fresh green tones. Purple Kush derivatives also show humulene and bisabolol in meaningful amounts, adding wood-spice and soothing floral sweetness.
For CBD #1 x Purple PCK 2002, expect profiles such as: myrcene 0.3–0.9% w/w, beta-caryophyllene 0.2–0.6%, limonene 0.1–0.4%, with supporting linalool 0.05–0.25% and humulene 0.05–0.2% in well-grown samples. Total terpene content of 1.5–3.0% is a realistic benchmark when drying and curing are controlled. Cooler finishing temperatures typically raise perceived berry intensity by preserving monoterpenes.
Caryophyllene’s CB2 receptor activity is often cited for inflammation-modulating potential, while myrcene is associated with musky fruit and potential sedation in user reports. Limonene provides citrus uplift, and linalool contributes lavender-like calm. These compounds, alongside minor terpenes (nerolidol, farnesene, and ocimene), shape the jammy-hashy signature that defines the Purple PCK side of the cross.
Experiential Effects and Use Cases
User experiences hinge on phenotype, but CBD-dominant expressions are consistently described as clear-headed, body-lightening, and anxiolytic with minimal impairment. Onset by inhalation generally occurs within 1–3 minutes, peaks around 15–30 minutes, and tapers over 2–4 hours. Many users note reduced racing thoughts and an easier transition into rest without the heavy mental fog of high-THC Kush.
Balanced phenotypes add warmer euphoria, heavier eyelids, and stronger physical comfort, particularly in the shoulders and lower back. THC-leaning phenotypes can feel decidedly classic-indica: blissful heaviness, couchlock, and time dilation, with richer sensory depth. The purple phenotype sometimes creates an expectation of strong sedation, but the CBD-dominant plants retain functional composure for daytime relief.
As always, dose moderates outcome: one small inhalation from a flower vaporizer delivers roughly 2–5 mg total cannabinoids depending on device and packing density. New users often benefit from titrating slowly across 2–3 inhalations spaced 5–10 minutes apart. Combining the flower with a 1–2 mg CBD tincture before inhalation can smooth the ramp-up in balanced phenotypes.
Potential Medical Applications (Evidence-Informed, Not Medical Advice)
CBD-forward expressions of this cross may interest users seeking relief from anxiety, inflammatory discomfort, and sleep disturbances without pronounced intoxication. Randomized trials and meta-analyses indicate CBD can reduce public-speaking anxiety at single oral doses of 300–600 mg, though inhaled flower will typically deliver far less per session. Observational studies across medical cannabis cohorts show improved sleep quality and decreased pain interference when CBD-containing chemotypes are used alongside or instead of high-THC flower.
For neuropathic and musculoskeletal pain, balanced CBD:THC (≈1:1) formulations have demonstrated small-to-moderate effect sizes in pooled analyses, with many patients preferring the functional relief profile over high-THC sedation. Beta-caryophyllene’s CB2 activity has been explored preclinically for inflammation, while linalool and myrcene are studied for calming and analgesic potential. While these data do not directly test CBD #1 x Purple PCK 2002, the chemotype logic aligns with patterns observed in similar ratios and terpene ensembles.
Individuals sensitive to THC may find the CBD-dominant phenotype helpful for daytime anxiety modulation and muscle tension. Those with insomnia might prefer a balanced phenotype in the evening where THC adds sleep initiation, and CBD helps sleep maintenance, as suggested in mixed-cannabinoid sleep studies. Always consult a clinician for personalized guidance, start low, and verify cannabinoid content with a lab certificate of analysis.
Comprehensive Cultivation Guide: Indoors, Greenhouse, and Outdoors
Environment and structure: Being mostly indica, CBD #1 x Purple PCK 2002 prefers moderate temperatures and stable VPD. Aim for day temps of 24–27°C (75–81°F) in veg and 23–26°C (73–79°F) in early flower, with night temps 18–21°C (64–70°F). In late flower, a 10–15°F drop at night encourages purple pigmentation without stalling metabolism.
Humidity targets of 60–65% RH in early veg, 50–55% in late veg/early flower, and 45–50% in late flower keep leaf turgor healthy while limiting Botrytis risk. Under LEDs, supply 600–900 μmol/m²/s PPFD in flower for compact buds; advanced growers can push 900–1,050 μmol/m²/s with elevated CO2 (900–1,200 ppm). A daily light integral (DLI) of 30–45 mol/m²/day in flower is a practical target for dense indica colas.
Medium and nutrition: The cultivar thrives in well-aerated coco or living soil with ample calcium and magnesium. In coco/hydro, maintain pH 5.8–6.2; in soil, 6.2–6.8. Typical EC ranges: 1.2–1.5 mS/cm in mid veg, 1.6–1.9 mS/cm in early flower, and 1.8–2.1 mS/cm during peak bulking, tapering to 0.8–1.2 in a 7–10 day fade.
Nitrogen should be generous in veg but reduced after week 3 of flower to avoid leafy colas. Supply extra potassium and phosphorus in weeks 4–7 of flower to support calyx swell, along with sulfur to enhance terpene synthesis. Foliar Ca/Mg during early stretch prevents interveinal chlorosis in high-intensity LED rooms.
Training and canopy: The compact structure takes well to topping once at the 5th node, followed by low-stress training or a light SCROG. Supercropping works on more vigorous phenotypes to even the canopy and increase light penetration. Expect minimal lateral stretch (1.2–1.8x) after flip, easing height management in tents and closets.
Irrigation strategy: In fabric pots, water to 10–20% runoff, allowing media to reach 50–60% field capacity before refeeding. Automated drip in coco with multiple small irrigations per day (especially at high PPFD) stabilizes EC and reduces salt spikes. Outdoors, 25–50 L containers (7–13 gal) balance root mass and portability; in-ground beds produce the heaviest yields if drainage is excellent.
Pest a
